Congress Main Topics

• Special session for patients’ advocacy group

• Advances in disease biology

• Immunotherapy: from the bench to the bedside

• Treatment guidelines for the young patients

• Outcome prediction

• Choice of therapy for non-transplant eligible patients

• Guidelines in specific clinical situations

• Treatment of relapse

• Expert advice on How I manage myeloma?

• Options for refractory myeloma

• Ongoing clinical trials and future trials

• Are we ready to personalize therapy today?

• CAR T cells in myeloma

• Smoldering myeloma should be treated very early

• Cost of therapy

• Practical guidelines for the practicing physician

• The future of myeloma therapy

• AL amyloidosis: update on biology and therapy

• Waldenstrom macroglobulinemia: update on biology and therapy